1. HOME
2. Research Insight
3. STERIS plc. (US) and Getinge AB (Sweden) are Leading Players in the Infection Control Market

The global infection control market is projected to reach USD 69.2 billion by 2029 from USD 51.0 billion in 2024, growing at a CAGR of 6.3% during the forecast period. The global infection control market has experienced significant growth driven by several key factors in recent years. One prominent factor is the high incidence of Healthcare-Associated Infections (HAIs), prompting healthcare facilities to invest in infection prevention and control measures. Additionally, the rising number of surgical procedures worldwide has led to increased demand for infection control products and solutions to minimize the risk of post-operative infections. Furthermore, the expanding geriatric population has contributed to market growth, as elderly individuals are more susceptible to infections and often require healthcare interventions. Moreover, the growing prevalence of chronic diseases among the aging population has heightened the need for infection control strategies to manage complications effectively. These factors collectively underscore the importance of infection control measures, driving the market's expansion to address the evolving healthcare landscape.

Prominent players in the infection control market include STERIS plc. (US), Getinge AB (Sweden), Ecolab, Inc. (US), 3M Company (US), Advanced Sterilization Products (US), Sotera Health LLC (US), MMM Group (Germany), MATACHANA GROUP (Spain), Belimed AG (Switzerland), Metrex Research LLC (US), Reckitt Benckiser (UK), Pal International (UK), Olympus Corporation (Japan). Melag Medizintechnik GmbH & Co. KG (Germany), Miele Group (Germany), Systec GmbH & Co. KG (Germany), Contec, Inc. (US), Continental Equipment Company (US), MEDALKAN (Greece), C.R.M. S.R.L. Medical Equipment (Italy), and Spire Integrated Solutions (US).

To know about the assumptions considered for the study download the pdf brochure

STERIS PLC (US)

STERIS plc, a prominent player in the infection control sector, is recognized for its leading position in providing sterilization products and services. The company's extensive product lineup stands as a cornerstone of its competitive advantage. STERIS offers a diverse range of contract processing services, employing gamma irradiation, electron beam processing, and EtO technologies, alongside laboratory testing services. Its geographic footprint spans across North America, Latin America, Europe, Asia, and the Middle East & Africa, with primary revenue streams stemming from the US market. STERIS holds a dominant position in both sterilization products/services and disinfectants markets. To reinforce its market leadership, the company pursues a blend of organic and inorganic growth strategies, including product launches, acquisitions, and collaborations. In a recent development, STERIS enhanced its product portfolio through the introduction of advanced infection control technologies, augmenting its market presence. Additionally, STERIS actively seeks to bolster its global presence through acquisitions of smaller to mid-sized players, evident in recent purchases like Key Surgical (US) and Medisafe Group (UK).

Getinge AB (Sweden)

Getinge AB, a key player in the sterilization products and disinfectants markets, boasts an expansive infection control product portfolio, featuring flusher disinfectors, washer-disinfectors, and cart washer-disinfectors. With a focus on North America and Europe, particularly the US market, which contributed 33% of its total sales in 2022, the company caters to a diverse clientele including hospitals, medical device and pharmaceutical companies, and universities. Notably, in October 2023, Getinge acquired Healthmark Industries Co. Inc., an US-based leading provider of innovative instrument care and infection control consumables. Leveraging both organic and inorganic growth strategies such as product launches, agreements, and acquisitions, Getinge continuously reinforces its market position. Over the past three years, it has introduced several innovative products like steam sterilizers, washer-disinfectors, and biological indicators, aimed at enhancing procedure efficiency and reducing processing time in sterilization and disinfection processes.

Ecolab, Inc. (US)

Ecolab Inc., a renowned global leader in infection prevention and water and hygiene solutions and services, boasts an extensive portfolio catering to various sectors such as food, healthcare, hospitality, and industrial markets. With a focus on advancing food safety, maintaining clean environments, optimizing water and energy usage, and enhancing operational efficiencies and sustainability, Ecolab provides personalized services and data-driven insights to its diverse clientele. Its product range includes detergents, cleaners, sanitizers, disinfectants, surface wipes, cleaning systems, electronic dispensers, and chemical injectors for chemical product application. Operating in 170 countries and serving nearly 3 million customer locations worldwide, Ecolab maintains a direct presence in over 90 countries outside the US, reinforcing its global reach and market dominance.

Related Reports:

Infection Control Market by Product (Sterilization (Hydrogen Peroxide, EtO, Gamma, E-Beam), Disinfection (Wipes, Liquids, Disinfectors), Services, Gowns, Endoscope Reprocessing), End User (Hospital & Clinics, Pharmaceuticals) - Global Forecast to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]